Abstract
The objective of this study is to determine the trend and diversity of binary toxin-positive Clostridioides difficile over 10 years in Korea. Binary toxin-positive strains were selected from a tertiary hospital in Korea in 2009–2018. The multi-locus sequence typing and antibiotic susceptibility test were performed. Among the 3278 isolates in 2009–2018, 58 possessed binary toxin genes (1.7%). The proportion of CDT- positive isolates was 0.51–4.82% in 2009–2018, which increased over the 10-year period (P = 0.023). Thirteen sequence types (STs) were identified; ST5 (14 [24%]), ST11 (11 [19%]), ST221 (10 [17%]), ST201 (7 [12%]) and ST1 (5 [9%]) were popular. All 58 isolates were susceptible to vancomycin and piperacillin/tazobactam, and clindamycin and moxifloxacin were active in 69.0% and 62% of isolates, respectively. ST1 strains were resistant to several antibiotics, including moxifloxacin (80%), clindamycin (60%) and rifaximin (60%). Moreover, four of five ST1 presented a metronidazole minimum inhibitory concentration of 4 µg/mL. Moxifloxacin resistance was highest (72.3%) for ST11. In conclusion, binary toxin-positive strains are non-prevalent in Korea and involve diverse STs. ST1 strains were resistant to several antibiotics.
Similar content being viewed by others
Introduction
Clostridioides difficile infection (CDI) is a common intestinal infection following disturbance of the gut microbiota, and mostly caused by antibiotic use. Over the last 10 years, binary toxin-positive strains of C. difficile have increased dramatically in North America and Europe, and epidemic strains have been identified as polymerase chain reaction (PCR) ribotype 027, REA group BI, and PFGE-type NAP1 (027/BI/NAP1)1. These strains produce binary toxin (CDT) in addition to toxin A (TcdA) and toxin B (TcdB), the main pathogenic toxins of C. difficile, and show other changes including fluoroquinolone resistance and 18-base pair deletion of the tcdC gene in the pathogenicity locus (PaLoc)2. Another important binary toxin-positive strains were identified in Netherland and other countries; the epidemic strains were PCR ribotype 078, REA group BK, and PFGE type NAP7 or NAP7,8 (078/BK/NAP7,8)3. The strains also produce binary toxins and have a deletion and stop codon in the tcdC gene3. Those epidemic binary toxin-positive strains are known to cause more severe infections with a poorer outcome, possibly because of virulence factors including binary toxins and hyperproduction of TcdA and TcdB due to deletion mutations in the tcdC gene4.
Besides these epidemic strains, other strains carry binary toxins whose clinical implications are not yet clear5,6,7. In the Asia–Pacific region, binary toxin-positive ribotype 027 strains are not prevalent in most countries, and epidemics of ribotype 027 or 078 have not been reported8. Likewise, an increase in CDI caused by binary toxin-positive strains has not been observed8,9, and clinical implication of binary-positive C. difficile isolates was not proved9.
In this study, to determine the trend and diversity of binary toxin-positive C. difficile over 10 years, we selected the CDT-positive isolates among all the isolates in 2009–2018 in one university hospital in Korea, and performed multi-locus sequence typing (MLST) and antibiotic susceptibility tests.
Results
Among the 3278 isolates in 2009–2018, 58 possessed binary toxin genes (1.7%). One to twelve binary toxin-positive C. difficile strains were observed annually (Fig. 1). The prevalence of CDT- positive isolates was 0.51–4.82% in 2009–2018, and the proportion of binary toxin-positive isolates increased over the 10-year period (P = 0.023).
MLST distribution and phylogenetic analysis
All 13 STs typed in this study were compatible with other STs available in the online MLST C. difficile database. Among the 58 strains, 13 belonged to clade 2 (22.4%), 31 to clade 3 (53.5%), 12 to clade 5 (20.7%), and 2 to an unknown clade (3.5%). Thirteen STs were identified; ST5 (14 [24%]), ST11 (11 [19%]), ST221 (10 [17%]), ST201 (7 [12%]) and ST1 (5 [9%]) were popular strains (Table 1 and Fig. 2). In particular, ST11 strains appeared to have increased since 2011, and three of the five binary-producing strains in 2018 were ST11. However, the number of ST5 strains, most commonly found in 2009, decreased since 2013. ST1 had a similar annual incidence since its first identification in 2011.
Clade 2 contains the most diverse STs: ST1, five isolates; ST192, three isolates; ST67, ST97, ST130, ST232, ST371, one isolate each; and ST1 and ST192 were the most popular strains. Clade 3 was composed of three STs: ST5, 14 isolates; ST201, seven isolates; and ST221, 10 isolates. Among the isolates of clade 5, ST11 was the most common (11 isolates), and one ST415 strain was found. Two ST122 strains belonging to an unknown clade were identified in 2014 (Fig. 3).
A neighbor-joining tree was constructed using the concatenated sequences of the seven loci used in MLST (Fig. 3). STs were clustered into four groups, designated as 2, 3, 5, and undetermined. ST122 which was placed on the root of lineage 2, was designated as novel lineage 6 in a previous report10.
Antibiotic susceptibility of binary toxin-positive C. difficile isolates
Table 1 presents the resistance rates of the 58 isolates to the six antibiotics. All isolates were susceptible to VAN and TZP, but CLI and MXF were active in 68.9% and 62.1% of the isolates, respectively. Five isolates (8.6%) were resistant to RFX and MTZ.
When we examined antibiotic susceptibility by ST type, ST1 strains showed a higher antibiotic resistance rate than other ST strains: MXF (80%), CLI (60%) and RFX (60%). Furthermore, 4 of 5 ST1 isolates presented an MTZ MIC of 4 µg/mL; thus the geometric mean MIC of MTZ was the highest among the ST1 isolates. One isolate of ST371, a strain closely related to ST1 according to MLST phylogeny, presented similar antibiotic susceptibility to ST1 (resistance [R] to CLI and intermediate resistance [IR] to MXF). The strains belonging to clade 3 did not present a high resistance rate to antibiotics: approximately 10% IR or R to CLI and approximately 10% IR to MXF. Among clade 5 strains composed of 11 ST11 and one ST415, MXF resistance was high (72.7%), but 27.3% and 9% of the isolates were resistant to CLI and RFX for ST11 strains. ST415 isolate had an MTZ MIC of 4 µg/mL. Two ST122 isolates belonging to a novel lineage showed 100% and 50% resistance to MXF and CLI, respectively.
Discussion
Binary toxins (CDTs) belong to the family of binary ADP-ribosylating toxins consisting of two separate toxin components: CDTa, the enzymatic ADP-ribosyltransferase which modifies actin; and CDTb which binds to host cells and translocates CDTa into the cytosol. ADP-ribosylation induces depolymerization of the actin cytoskeleton, which produces membrane protrusions and aids bacterial adherence2. CDT production is associated with increased CDI severity2,4,6,7. Some binary toxin-positive strains have a tcdC-truncating mutation, a negative regulator of tcdA and tcdB, which may increase the infection severity11. However, truncating mutations in tcdC alone did not cause a difference in patient’ outcomes, although it was related to leukocytosis and C-reactive protein elevation7.
In this study, during the years of 2009–2018 at a university hospital in Korea, binary toxin-positive strains are not frequently encountered, and the epidemic binary-positive hypervirulent strains are not prevalent. Instead, ST-type strains in diverse clades existed in the hospital. However, ST11 strains showed a tendency to increase in this study, and similar findings were noticed in Taiwan and mainland China, but not in Japan12,13,14,15. High resistance to MXF of ST11 was commonly observed12, and high resistance to tigecycline was reported13. ST11/R078 strains began to be detected in 2011 and 2012 in the Asian countries12. R078 families are initially the predominant ribotype in production animals in the USA and Europe, and then in humans in Europe. Frequent presence of R078 in meat products suggests a possible transmission from animals to humans16. In terms of R027 isolates, they have not spread among Asian countries after the first introduction in Korea, Hong Kong and Australia in 2008–201017,18,19. Despite hospital crowding, high levels of antibiotic (particularly fluoroquinolone) use, and huge aging population with multiple comorbidities, ST1 strains have not increased in these countries without clear explanation.
Binary-positive isolates from different clades showed different pattern of antibiotic susceptibility in this study. Despite a similar low prevalence, the epidemic hypervirulent ST1 and ST11 showed the higher resistance to most antibiotics. ST 371 most closely related to ST1 was resistant to MXF and CLI. Especially, ST1 showed 80% (4/5) of MTZ resistance despite MTZ resistance in C. difficile is rare. Those isolates showed the MIC of 4 µg/mL, and they were not considered from a single clone because all of them were from different years (1 isolate per year). It would be interesting to study the clonality and MTZ resistance mechanisms of those isolates.
MTZ resistance mechanisms in C. difficile are not clearly understood but are likely multifactorial processes involving alterations to metabolism such as with nitroreductase, iron uptake, DNA repair or biofilm formation20,21. Recently, MTZ resistance mediated by a high-copy number 7 kb plasmid (pCD-METRO) in C. difficile was discovered, which increased the MIC 25-fold22. The pCD-METRO was present in RT027 and non-toxigenic RT010 isolates from several countries. C. difficile RTs 027, 106, 001/072, 206, 010 and 356 strains had increased mean metronidazole MICs compared to other strains20.
Briefly reviewing the several binary-positive ST-types, all the ST-types below are positive for both toxin A and toxin B genes and the binary toxin genes. The ST67 strain, first reported in Japan did not contain an 18-base pair (bp) deletion or a one-bp deletion at position 117 in in tcdC, although it harbored eight nucleotide substitutions. The cytotoxicity of this strain was similar to that of ATCC BAA-1870 (RT027/ST1)11. ST5 and ST201 belonging to clade 3 have been sequenced in China23. The ST5 strain harbored a 54-bp consecutive deletion that resulted in a truncated TcdC protein, and ST201 also encodes a truncated TcdC. The ST122 strain, first isolated from Kuwait, contains an 18-bp deletion in the tcdC gene10. The phylogenetic analysis using a reference collection (Leeds-Leiden/ECDC) formed a well-separated sister clade to the clade formed by lineages 1 and 2, and the authors suggested a potential new lineage10. In our analysis, ST122 formed a separate lineage on the roots of lineage 2.
In summary, the proportion of binary toxin-positive strains was 1.7% among the 3278 isolates in 2009–2018. An epidemic strain of ST1 is not prevalent in Korea. The MLST analysis revealed diverse ST distributions in clades 2, 3, and 5. ST1 strains were more resistant to several antibiotics than other strains.
Material and methods
Study design and definition
This study was conducted at Hanyang University Hospital, a 900-bed tertiary care facility in Seoul, Korea. The study was approved by the institutional review board of Hanyang University Hospital (HYUH IRB 2016–01-031), which waived the need for informed consent.
All patients who had a CDI (as defined in the following paragraph) in 2009–2018 were identified through medical chart review, and the isolates from these patients were collected and stored. Diarrhea was defined as unformed stools more than three times per day on consecutive days or six times within 36 h24. The diagnosis of CDI was made using toxigenic culture, a commercial toxin A&B assay kit (VIDASⓇ C. difficile toxin A & B; BioMerieux SA, Marcy l’Etoile, France), and/or pseudomembrane on endoscopy2. Isolates from patients with CDI were tested by multiplex PCR25, and the isolates with CDT genes (cdtA and cdtB) were included.
Isolation of C. difficile and detection of toxin genes by multiplex PCR
After alcohol shock treatment, stool specimens were cultivated on C. difficile moxalactam–norfloxacin–taurocholate agar (CDMN-TA agar; Oxoid Ltd., Cambridge, UK), supplemented with 7% horse blood26. Colonies of C. difficile were identified using Rapid ID 32A (BioMerieux SA). To identify the toxin genes, multiplex PCR was performed using template DNA, as described previously25. The positive controls were ATCC 43598 (PCR RT017), ATCC 9689 (PCR RT027), VPI 10643 (ATCC 43255, PCR RT087) and ATCC 700057, which represent A–B+CDT–, A+B+CDT+, A+B+CDT–, and A–B–CDT– RTs, respectively.
Multi-locus sequence typing
Seven conserved housekeeping genes adk, atpA, dxr, glyA, recA, sodA, and tpi were sequenced27, and isolates were assigned to sequence types (STs) and clades in the C. difficile MLST database (https://pubmlst.org/organisms/clostridioides-difficile).
Antibiotic susceptibility
The minimum inhibitory concentrations (MICs) of six antibiotics—metronidazole (MTZ), vancomycin (VAN), piperacillin/tazobactam (TZP), clindamycin (CLI), moxifloxacin (MXF) and rifaximin (RFX)—were determined. Brucella agar containing hemin (5 µg/mL), vitamin K1 (10 µg/mL), and 5% horse blood was used28. The MICs of CLI, MXF, and VAN were determined using Etest (AB-BIODISK, Solna, Sweden), while those of MTZ, RFX, and TZP were determined using the agar dilution test (Sigma-Aldrich, St. Louis, MO, USA). C. difficile ATCC 700057 was used as the control strain for the susceptibility tests. Resistance breakpoints were defined by the Clinical Laboratory and Standards Institute and European Committee on Antimicrobial Susceptibility Testing28,29.
Phylogenetic analysis
A phylogenetic tree of the 13 STs was constructed using the seven housekeeping genes of the MLST. Each gene was separately aligned over 13 STs, and seven genes were concatenated for each ST. For the tree construction, the maximum likelihood method with the Tamura-Nei model was applied using MEGA630. The robustness of the nodes was evaluated using the bootstrap method with 1000 replicates.
Statistical methods
SPSS version 18.0 for Windows (SPSS Inc., Chicago, IL, USA) was used for the statistical analysis. A logistic regression analysis was performed, as appropriate. Statistical significance was set at P < 0.05.
Ethics statement
The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of Hanyang University (protocol code 2016-01-031 and date of approval), and the requirement for written informed consent from patients was waived.
Data availability
The original contributions of this study are included in this article. Further enquiries can be directed to the corresponding author.
References
McDonald, L. C. et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353, 2433–2441. https://doi.org/10.1056/NEJMoa051590 (2005).
Gerding, D. N., Johnson, S., Rupnik, M. & Aktories, K. Clostridium difficile binary toxin CDT: Mechanism, epidemiology, and potential clinical importance. Gut. Microbes 5, 15–27. https://doi.org/10.4161/gmic.26854 (2014).
Goorhuis, A. et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis. 47, 1162–1170. https://doi.org/10.1086/592257 (2008).
See, I. et al. NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin. Infect. Dis. 58, 1394–1400. https://doi.org/10.1093/cid/ciu125 (2014).
Stubbs, S. et al. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol. Lett. 186, 307–312. https://doi.org/10.1111/j.1574-6968.2000.tb09122.x (2000).
Bacci, S., Mølbak, K., Kjeldsen, M. K. & Olsen, K. E. Binary toxin and death after Clostridium difficile infection. Emerg. Infect. Dis. 17, 976–982. https://doi.org/10.3201/eid/1706.101483 (2011).
Goldenberg, S. D. & French, G. L. Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile. J. Infect. 62, 355–362. https://doi.org/10.1016/j.jinf.2011.03.001 (2011).
Luo, Y. et al. Different molecular characteristics and antimicrobial resistance profiles of Clostridium difficile in the Asia-Pacific region. Emerg. Microbes Infect. 8, 1553–1562. https://doi.org/10.1080/22221751.2019.1682472 (2019).
Kim, J., Seo, M. R., Kang, J. O., Choi, T. Y. & Pai, H. Clinical and microbiologic characteristics of clostridium difficile infection caused by binary toxin producing strain in Korea. Infect. Chemother. 45, 175–183. https://doi.org/10.3947/ic.2013.45.2.175 (2013).
Knetsch, C. W. et al. Comparative analysis of an expanded Clostridium difficile reference strain collection reveals genetic diversity and evolution through six lineages. Infect. Genet. Evol. 12, 1577–1585. https://doi.org/10.1016/j.meegid.2012.06.003 (2012).
Saito, R. et al. Hypervirulent clade 2, ribotype 019/sequence type 67 Clostridioides difficile strain from Japan. Gut. Pathog. 11, 54. https://doi.org/10.1186/s13099-019-0336-3 (2019).
Hung, Y. P. et al. Predominance of clostridium difficile ribotypes 017 and 078 among toxigenic clinical isolates in southern Taiwan. PLoS ONE 11, e0166159. https://doi.org/10.1371/journal.pone.0166159 (2016).
Hung, Y. P. et al. Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic Clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan. Infect Drug Resist 11, 1197–1203. https://doi.org/10.2147/idr.S162874 (2018).
Liu, X. S., Li, W. G., Zhang, W. Z., Wu, Y. & Lu, J. X. Molecular characterization of clostridium difficile isolates in China from 2010 to 2015. Front. Microbiol. 9, 845. https://doi.org/10.3389/fmicb.2018.00845 (2018).
Riley, T. V. & Kimura, T. The epidemiology of clostridium difficile infection in Japan: A systematic review. Infect Dis Ther 7, 39–70. https://doi.org/10.1007/s40121-018-0186-1 (2018).
Goorhuis, A. et al. Clostridium difficile PCR ribotype 078: An emerging strain in humans and in pigs?. J Clin Microbiol 46, 1157. https://doi.org/10.1128/jcm.01536-07 (2008).
Clements, A. C., Magalhães, R. J., Tatem, A. J., Paterson, D. L. & Riley, T. V. Clostridium difficile PCR ribotype 027: Assessing the risks of further worldwide spread. Lancet Infect. Dis. 10, 395–404. https://doi.org/10.1016/s1473-3099(10)70080-3 (2010).
Cheng, V. C. et al. Clostridium difficile ribotype 027 arrives in Hong Kong. Int. J. Antimicrob. Agents 34, 492–493. https://doi.org/10.1016/j.ijantimicag.2009.04.004 (2009).
Tae, C. H. et al. The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea. J. Kor. Med. Sci. 24, 520–524. https://doi.org/10.3346/jkms.2009.24.3.520 (2009).
O’Grady, K., Knight, D. R. & Riley, T. V. Antimicrobial resistance in Clostridioides difficile. Eur. J. Clin. Microbiol. Infect. Dis. 40, 2459–2478. https://doi.org/10.1007/s10096-021-04311-5 (2021).
Spigaglia, P., Mastrantonio, P. & Barbanti, F. Antibiotic Resistances of Clostridium difficile. Adv. Exp. Med. Biol. 1050, 137–159. https://doi.org/10.1007/978-3-319-72799-8_9 (2018).
Boekhoud, I. M. et al. Plasmid-mediated metronidazole resistance in Clostridioides difficile. Nat. Commun. 11, 598. https://doi.org/10.1038/s41467-020-14382-1 (2020).
Peng, Z. et al. Genome characterization of a novel binary toxin-positive strain of Clostridium difficile and comparison with the epidemic 027 and 078 strains. Gut. Pathog. 9, 42. https://doi.org/10.1186/s13099-017-0191-z (2017).
McFarland, L. V. Risk factor for antibiotic-associated diarrhea: A review of the literature. Ann. Med. Interne (Paris) 149, 261–266 (1998).
Persson, S., Torpdahl, M. & Olsen, K. E. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clin. Microbiol. Infect. 14, 1057–1064. https://doi.org/10.1111/j.1469-0691.2008.02092.x (2008).
Clabots, C. R., Gerding, S. J., Olson, M. M., Peterson, L. R. & Gerding, D. N. Detection of asymptomatic Clostridium difficile carriage by an alcohol shock procedure. J. Clin. Microbiol. 27, 2386–2387. https://doi.org/10.1128/jcm.27.10.2386-2387.1989 (1989).
Griffiths, D. et al. Multilocus sequence typing of Clostridium difficile. J. Clin. Microbiol. 48, 770–778. https://doi.org/10.1128/jcm.01796-09 (2010).
CLSI. Standard Methods for antimicrobial susceptibility testing of Anaerobic bacteria; Approved standard M11-A7. 7th ed. Wayne, PA. (2007).
EUCAST. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters Version 5.0. (2015).
Tamura, K. & Nei, M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol. Biol. Evol. 10, 512–526 (1993).
Funding
This research was supported by a research fund from the Korea Disease Control and Prevention Agency for 2020 (2020-ER5409-00).
Author information
Authors and Affiliations
Contributions
H.P. designed the study. J.K. and B.K. organized the database and performed the statistical analysis. All authors contributed to write the manuscript and approved the submitted version.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kim, J., Kim, B. & Pai, H. Diversity of binary toxin positive Clostridioides difficile in Korea. Sci Rep 13, 576 (2023). https://doi.org/10.1038/s41598-023-27768-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-27768-0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.